Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2026)
Harmony Biosciences Holdings recorded quarterly Inventory of $5.4 million in Q1 2026, down 1.38% quarter-over-quarter from $5.5 million in Q4 2025, and down 16.84% year-over-year from $6.5 million in Q1 2025.
Harmony Biosciences Holdings' Inventory history runs 8 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Inventory fell 16.84% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (down 16.84% YoY), while the FY2025 annual figure was $5.5 million, down 23.3% from the prior year.
- Inventory came in at $5.4 million for Q1 2026 at Harmony Biosciences Holdings, down from $5.5 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $7.2 million in Q4 2024 to a low of $4.1 million in Q1 2023.
- A 5-year average of $5.6 million and a median of $5.4 million in 2026 frame the typical range for Inventory.
- Across the five-year window, Inventory soared 43.2% in 2024 and retreated 23.3% in 2025, its largest moves.
- Harmony Biosciences Holdings' Inventory stood at $4.3 million in 2022, then advanced by 24.81% to $5.4 million in 2023, then surged by 34.22% to $7.2 million in 2024, then declined by 23.3% to $5.5 million in 2025, then fell by 1.38% to $5.4 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $5.4 million, $5.5 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | 5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 6.88 Mn |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 5.36 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.09 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 4.66 Mn |
| Mar 31, 2022 | 5.05 Mn |
| Dec 31, 2021 | 4.43 Mn |
| Sep 30, 2021 | 5.25 Mn |
| Jun 30, 2021 | 4.95 Mn |
| Mar 31, 2021 | 4.71 Mn |
| Dec 31, 2020 | 3.82 Mn |
| Sep 30, 2020 | 2.37 Mn |
| Dec 31, 2019 | 1.09 Mn |